Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20127054 | 0.93 | PTPN1 (0.34) | PTPN1PTPN2PTPN6 | |
| SCHEMBL18789374 | 0.79 | PLA2G2A (0.33) | — | |
| SCHEMBL20021862 | 0.78 | GABRA1 (0.38) | — | |
| SCHEMBL18789376 | 0.76 | GABRA1 (0.39) | — | |
| SCHEMBL18789377 | 0.73 | CYP1A2 (0.34) | — | |
| SCHEMBL18789381 | 0.72 | ATM (0.32) | — | |
| SCHEMBL18926383 | 0.70 | ALDH1A1 (0.40) | — | |
| SCHEMBL17342250 | 0.69 | ALDH1A1 (0.44) | — | |
| SCHEMBL18661329 | 0.68 | ALDH1A1 (0.40) | — | |
| SCHEMBL20468483 | 0.67 | NPC1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127333-A1 | CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION AND METHOD FOR OLEFIN OLIGOMERIZATION USING THE SAME | LG CHEM, LTD. (KR) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127333-A1 | CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION AND METHOD FOR OLEFIN OLIGOMERIZATION USING THE SAME | OXER1, OSTC, COG7 | PTPN1 4790/4885PTPN2 4804/4885PTPN6 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.